Bausch Health will remove several drugs from the 340B and Medicaid rebate programs effective Oct. 1.

Bausch Health Removes High-Cost Liver Disease, GI Treatment, Many Other Drugs From 340B and Medicaid Rebate Programs

September 23, 2025 Shannon Young, Associate Editor/Senior Writer 340B Report Views

340B hospitals looking to use Xifaxan could soon have to pay thousands for the commonly used hepatic encephalopathy and irritable [...]

Please Login or Become a Paid Subscriber to View this Content

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!